Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 197

The DOI matches its Crossref record.

IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS

Open access
Bennett, Martin R · 2003 · Heart

Abstract

ver 1.5 million percutaneous coronary revascularisation procedures are performed annually world wide, most being intracoronary stenting.Despite enormous advances in devices, the major limitation is in-stent stenosis (ISS) (reviewed by Bennett and O'Sullivan 1 ).Although ISS rates are 10-20% in selected patients, we now stent total occlusions, saphenous vein bypass grafts, both angioplasty and ISS sites, diabetic patients, and small vessels.Thus, real ISS rates are much higher, up to 59% in some high risk lesions.Until recently, the only effective treatment for ISS was brachytherapy.Brachytherapy reduces target vessel revascularisation rates and binary restenosis rates, and increases minimum luminal diameters (MLDs) compared with control vessels, maintained to three years.1 Although effective, brachytherapy is not universally accepted, due predominantly to late thrombosis and the logistics of administering radioactivity.In contrast, drug eluting stents containing the immunosuppressive agent rapamycin and the antimitotic agent paclitaxel have shown encouraging reductions in ISS in de novo lesions, 2 3 and possibly in ISS lesions.This review examines the pathology of ISS and how drugs bound to stents interrupt the normal response to vessel injury. c MECHANISMS OF RESTENOSISOverdistension of the diseased vessel causes endothelial disruption, internal elastic lamina fracture, and medial dissection.Lumen enlargement is caused by a combination of plaque reduction (compression/embolisation), axial plaque redistribution towards the proximal and distal segments outside the stent, plaque extrusion, and vessel expansion.Many processes then contribute to restenosis (fig 1 and table 1). Elastic recoilThe human epicardial coronary arteries contain elastin fibres comprising the internal and external elastic laminae (IEL/EEL).Elastic recoil therefore follows overstretch, occurring between seconds and minutes following balloon deflation, resulting in up to 40% loss of luminal areas.Although both angioplasty and stenting produce overstretch injury, stenting significantly reduces acute recoil. Reorganisation of thrombusAngioplasty or stenting causes endothelial denudation and induces medial dissection.The consequent exposure of subintimal components such as collagen, Von Willebrand factor, fibronectin, and laminin causes platelet adherence and aggregation.Fibrin and platelets are deposited on stent struts early after implantation.The association of fibrin and platelets with neointimal accumulation and extensive neovascularisation at ISS sites suggests that organisation of mural thrombus promotes ISS. Neointimal formationArterial injury induces vascular smooth muscle cell (VSMC) proliferation and/or migration due to: (1) mechanical stretch, IEL rupture, and medial dissection; (2) endothelial denudation with exposure to circulating mitogens such as angiotensin II and plasmin; and (3) release of mitogens and cytokines from platelets, endothelial cells, VSMCs, and inflammatory cells.VSMCs are normally in the quiescent (G 0 ) phase of the cell cycle.In animal models, injury induces medial and then intimal cell cycle entry, following a wave of immediate early gene expression.Cells undergo either cell proliferation, migration or both, with subsequent synthesis of extracellular matrix and collagen, resulting in neointima formation.Neointimal formation is the major cause of ISS.Neointima increases up to three months after the procedure, with little change to six months, and a gradual reduction between six months and three years.However, the role of cell proliferation within the neointima remains controversial.Cell proliferation is low in specimens retrieved from ISS sites, although higher in ISS versus angioplasty restenosis sites.4 Although neointima formation after stenting is associated with medial disruption

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/heart.89.2.218

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 197

Metadata

Authors
Bennett, M. R.
Venue
Heart
Publisher
BMJ
Published
2003-02
Volume
89
Issue
2
Pages
218-224
ISSN
  • 1355-6037 (ISSN-L)
  • 1468-201X
OpenAlex
W2069465511
Cited by
197
References
0
FWCI
11.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS. https://app.cochat.ai/papers/10.1136/heart.89.2.218
The paper
Bennett, M. R. (2003). IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS. Heart. https://doi.org/10.1136/heart.89.2.218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.